Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Vonoprazan- Amoxicillin Dual Therapy for Helicobacter Pylori Eradication : a Prospective, Multicenter, Randomized Controlled Trial

NCT05469685 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT05469685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05469685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Vonoprazan- Amoxicillin Dual Therapy for Helicobacter Pylori Eradication : a Prospective, Multicenter, Randomized Controlled Trial
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2022
Completion date
September 30, 2023
Enrollment
914 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection